Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$979K Buy
13,523
+65
+0.5% +$3.94K 0.01% 976
2026
Q1
$659K Buy
13,458
+7,123
+112% +$333K 0.01% 1097
2025
Q4
$228K Sell
6,335
-2,185
-26% -$88.4K ﹤0.01% 1500
2025
Q3
$386K Sell
8,520
-7,172
-46% -$290K ﹤0.01% 1299
2025
Q2
$498K Buy
15,692
+2,884
+23% +$82.6K 0.01% 1052
2025
Q1
$382K Sell
12,808
-1,215
-9% -$42.8K 0.01% 1169
2024
Q4
$503K Buy
14,023
+6,219
+80% +$244K 0.01% 937
2024
Q3
$316K Buy
7,804
+1,880
+32% +$80.1K 0.01% 1114
2024
Q2
$277K Buy
+5,924
New +$260K 0.01% 1152

Other funds holding CGNX

Vident Advisory's CGNX Position: Q2 2026 in Review

Vident Advisory increased its Cognex (CGNX) stake by 0.48% in Q2 2026, buying an estimated $3.94K and bringing the position to 13,523 shares worth $979K. The position accounts for 0.01% of the portfolio, ranked #976.

Vident Advisory first reported a position in CGNX in Q2 2024 and has held it in 9 quarters since. 654 funds tracked by Wall St. Rank hold CGNX as of Q2 2026.

  • Vident Advisory held 13,523 shares of Cognex worth $979K as of Q2 2026.
  • Vident Advisory bought 65 Cognex shares in Q2 2026, an estimated $3.94K.
  • Cognex made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #976 holding.
  • Vident Advisory first reported a position in Cognex in Q2 2024 and has held it in 9 quarters since.
  • 654 funds tracked by Wall St. Rank held Cognex as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.